SEC
Whistleblower
Advocates

October 05, 2015

Bristol-Myers Squibb Company

Foreign Corrupt Practices Act

SANCTION AMOUNT: $14,692,000

Defendants: Bristol-Myers Squibb Company

Settlement of charges that Respondent's majority-owned joint venture in China made cash payments and provided other benefits to health care providers at state-owned and state-controlled hospitals in exchange for prescription sales, leading to profits in excess of $11 million.

Thank you for submitting some email to us.